Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132724) titled 'A Prospective Study on the Diagnosis of Malignant Tumors With 18F-FGIn PET/CT' on Sept. 17.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Condition:
Patients with clinical suspicion or possible primary or recurrent malignant tumors (such as gliomas, liver cancer, gastric cancer, duodenal cancer, colorectal cancer, ovarian cancer and other malignancies prone to false-negative or false-positive results with 18F-FDG)
Intervention:
Gold Standard:The diagnosis is confirmed through pathological or ...